Cervical cancer gene therapy by gene loaded PEG-PLA nanomedicine

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 12, 2014, Pages 4915-4918

  Liu, Bo ^a   Han, Shu Mei ^a   Tang, Xiao Yong ^a   Han, Li ^a   Li, Chang Zhong ^b  

^a SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Cervical cancer; Folate coating; Gene therapy; Targeted nanomedicine

Indexed keywords

DRUG CARRIER; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; MACROGOL DERIVATIVE; MONOMETHOXYPOLYETHYLENEGLYCOL-POLYLACTIDE BLOCK COPOLYMER; NANOPARTICLE;

APOPTOSIS; CELL CULTURE; CELL PROLIFERATION; FEMALE; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; NANOMEDICINE; PATHOLOGY; THERAPEUTIC USE; UMBILICAL VEIN ENDOTHELIAL CELL; UTERINE CERVICAL NEOPLASMS;

APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; DRUG CARRIERS; FEMALE; GENETIC THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NANOMEDICINE; NANOPARTICLES; POLYETHYLENE GLYCOLS; UTERINE CERVICAL NEOPLASMS;

EID: 84904619737     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.12.4915     Document Type: Article

References (35)

1. Aantic LG, Djikanovic BS, Antic DZ, et al (2014). Differencies in the level of knowledge on cervical cancer among health care students, midwives and patients in Serbia. Asian Pac J Cancer Prev, 15, 3011-5.
2. Buyens K, De Smedt SC, Braeckmans K, et al (2012). Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design. J Control Release, 158, 362-70.
3. Chen Y, Zhu X, Zhang X, et al (2010). Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol Ther, 18, 1650-6.
4. Elfinger M, Maucksch C, Rudolph C. (2007). Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells. Biomaterials, 28, 3448-55.
5. Elzoghby AO (2013). Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research. J Control Release, 172, 1075-91.
6. Filipi K, Xhani A (2014). Assessment of cervical cytological data in Albanian females. Asian Pac J Cancer Prev, 15, 2129-32.
7. Gao X, Tao W, Lu W, et al (2006). Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration. Biomaterials, 27, 3482-90.
8. Geiger J, Aneja MK, Hasenpusch G, et al (2010). Targeting of the prostacyclin specific IP1 receptor in lungs with molecular conjugates comprising prostaglandin I2 analogues. Biomaterials, 31, 2903-11.
9. Gersch ED, Gissmann L, Garcea RL (2012). New approaches to prophylactic human papillomavirus vaccines for cervical cancer prevention. Antivir Ther, 17, 425-34.
10. Kahla S, Kochbati L, Maalej M, et al (2014). Situation of HPV16 E2 gene status during radiotherapy treatment of cervical carcinoma. Asian Pac J Cancer Prev, 15, 2869-73.
11. Karadag G, Gungormus Z, Surucu R, et al (2014). Awareness and practices regarding breast and cervical cancer among Turkish women in Gazientep. Asian Pac J Cancer Prev, 15, 1093-8.
12. Lee H, Kim Y, Schweickert PG, et al (2014). A photodegradable gene delivery system for enhanced nuclear gene transcription. Biomaterials, 35, 1040-9.
13. Lin C, Huang F, Zhang YJ, et al (2014). Roles of MiR-101 and its target gene Cox-2 in early diagnosis of cervical cancer in Uygur women. Asian Pac J Cancer Prev, 15, 45-8.
14. Luu HN, Dahlstrom KR, Mullen PD, et al (2013). Comparison of the accuracy of Hybrid Capture II and polymerase chain reaction in detecting clinically important cervical dysplasia: a systematic review and meta-analysis. Cancer Med, 2, 367-90.
15. Ma JQ, Kurban S, Zhao JD, et al (2014). Epigenetic regulation of human riboflavin transporter 2 (hRFT2) in cervical cancers from Uighur women. Asian Pac J Cancer Prev, 15, 2485-9.
16. Meads C, Auguste P, Davenport C, et al (2013). Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling. Health Technol Assess, 17, 1-323.
17. Narayan G, Murty VV (2010). Integrative genomic approaches in cervical cancer: implications for molecular pathogenesis. Future Oncol, 6, 1643-52.
18. Parveen S, Misra R, Sahoo SK (2012). Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine, 8, 147-66.
19. Podolska K, Stachurska A, Hajdukiewicz K, Małecki M (2012). Gene therapy prospects--intranasal delivery of therapeutic genes. Adv Clin Exp Med, 21, 525-34.
20. Schädlich A, Caysa H, Mueller T, et al (2011). Tumor accumulation of NIR fluorescent PEG-PLA nanoparticles: impact of particle size and human xenograft tumor model. ACS Nano, 5, 8710-20.
21. Shi Y, Huang W, Liang R, et al (2013). Improvement of in vivo efficacy of recombinant human erythropoietin by encapsulation in PEG-PLA micelle. Int J Nanomedicine, 8, 1-11.
22. Takai N, Kira N, Ishii T, et al (2011). Novel chemotherapy using histone deacetylase inhibitors in cervical cancer. Asian Pac J Cancer Prev, 12, 575-80.
23. Tsai HC, Chang WH, Lo CL, et al (2010). Graft and diblock copolymer multifunctional micelles for cancer chemotherapy and imaging. Biomaterials, 31, 2293-301.
24. Tungsrithong N, Kasinpila C, Maneenin C, et al (2014). Lack of significant effects of Chlamydia trachomatis infection on cervical cancer risk in a nested case-control study in North-East Thailand. Asian Pac J Cancer Prev, 15, 1497-500.
25. Vachani A, Moon E, Wakeam E, et al (2011). Gene therapy for lung neoplasms. Clin Chest Med, 32, 865-85.
26. Wang S, Luo Y, Zeng S, et al (2013). Dodecanol-poly (D, L-lactic acid)-b-poly (ethylene glycol)-folate (Dol-PLA-PEG-FA) nanoparticles: evaluation of cell cytotoxicity and selecting capability in vitro. Colloids Surf B Biointerfaces, 102, 130-5.
27. Wang YQ, Su J, Wu F, et al (2012). Biscarbamate cross-linked polyethylenimine derivative with low molecular weight, low cytotoxicity, and high efficiency for gene delivery. Int J Nanomedicine, 7, 693-704.
28. Xia H, Gao X, Gu G, et al (2012). Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery. Int J Pharm, 436, 840-50.
29. Xiao RZ, Zeng ZW, Zhou GL, et al (2010). Recent advances in PEG-PLA block copolymer nanoparticles. Int J Nanomedicine, 5, 1057-65.
30. Yang S, Chen Y, Gu K, et al (2013). Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD4+ immune cells. Int J Nanomedicine, 8, 2847-58.
31. Yu DH, Lu Q, Xie J, et al (2010). Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature. Biomaterials, 31, 2278-92.
32. Yu W, Liu C, Liu Y, et al (2010). Mannan-modified solid lipid nanoparticles for targeted gene delivery to alveolar macrophages. Pharm Res, 27, 1584-96.
33. Zhao LW, Zhong XH, Yang SY et al (2014). Inotodiol inhabits proliferation and induces apoptosis through modulating expression of cycline, p27, bcl-2, and bax in human cervical cancer Hela cells. Asian Pac J Cancer Prev, 15, 3195-9.
34. Zhang L, Hu CH, Cheng SX, Zhuo RX (2010). Hyperbranched amphiphilic polymer with folate mediated targeting property. Colloids Surf B Biointerfaces, 79, 427-33.
35. Zhou X, Gu Y, Zhang SL (2012). Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: a HuGE review and meta-analysis. Asian Pac J Cancer Prev, 13, 4909-14.